• Estrogen–Autophagy Axis in Perimenopausal Aging

  2026-10-04

  A 2026 Life Sciences study integrates NHANES analysis, mouse experiments, and network pharmacology to examine how declining estradiol may affect the heart, aorta, and kidneys during perimenopausal aging. Its findings link estrogen receptor activity and autophagy signaling with reduced multi-organ fibrosis, while the evidence remains limited by observational human data, model dependence, and the interpretive limits of pharmacological inhibitors.

• Angiotensin 1/2 (1-6): A Systems Biology View

  2026-10-03

  Angiotensin 1/2 (1-6) is more than a short renin-angiotensin system fragment. This evidence-focused analysis connects its sequence, vascular and renal relevance, and emerging spike-receptor findings while distinguishing biochemical observation from biological and clinical interpretation.

• a-MSH, amide: From Stimulus to Assay Design

  2026-10-02

  Discover how a-MSH, amide can function as a defined biological stimulus rather than merely a pigmentation reagent. This article connects melanocortin signaling with assay architecture, orthogonal readouts, and careful interpretation of pigmentation and inflammation data.

• Staurosporine in THP-1 Apoptosis Workflows

  2026-10-01

  Build more reproducible apoptosis and kinase-signaling assays by pairing Staurosporine with cryopreservation-aware THP-1 cell handling. This workflow distinguishes compound-driven apoptosis from post-thaw stress while extending the reference study’s assay-ready cell strategy to cancer research and angiogenesis models.

• Pterostilbene and Dermal Fibroblast Senescence

  2026-10-01

  Zhou et al. report that pterostilbene reduces senescence in human dermal fibroblasts by improving mitochondrial quality, including membrane potential, respiration, morphology, and mitophagy-associated clearance. The study links mitochondrial maintenance with collagen preservation across cellular and UVB-exposed mouse models, providing a useful framework for investigating dermal aging mechanisms.

• Type III Collagen Restricts Breast Cancer Progression

  2026-09-30

  This study identifies type III collagen (Col3) as a tumor-restrictive component of the breast cancer microenvironment rather than merely a structural ECM protein. By integrating fibroblast-derived matrices, 3D cultures, patient data, bioinformatics, and mouse models, the authors connect higher Col3 relative to type I collagen with reduced tumor aggressiveness and improved clinical outcomes.

• Gallein: G Protein βγ Subunit Inhibitor Workflows

  2026-09-30

  Gallein is a practical pharmacological probe for testing G protein βγ-dependent signaling across metabolic, cancer, immune, and cardiac models. This workflow connects the lactate–GPR81/FARP1 pathway to assay design while clearly separating reference-backed findings from optimization recommendations.

• RIPA Lysis Buffer (Medium) for EV Signaling

  2026-09-29

  RIPA Lysis Buffer (Medium) connects extracellular-vesicle stimulation with pathway-focused protein analysis in cell and tissue models. Its balanced detergent system supports Western blotting and immunoassays, while formulation-aware handling helps protect phosphoproteins and preserve reproducibility.

• a-MSH, amide: Designing Causal Melanogenesis Assays

  2026-09-29

  Discover how a-MSH, amide can function as a defined melanocortin challenge ligand for pigmentation regulation research. This article translates α-MSH-induced melanogenesis findings into a rigorous assay strategy that separates receptor activity, melanin synthesis modulation, viability, and inflammation.

• Flumequine in DNA Topoisomerase II Assays

  2026-09-28

  Flumequine enables mechanism-focused studies of DNA topoisomerase II inhibition, DNA replication stress, and drug-response phenotypes. Its greatest practical value emerges when enzyme inhibition is separated from cellular proliferation arrest and cell killing in a time-resolved workflow.

• EZ Cap™ CPF1/Cas12a mRNA (m1Ψ) Workflow

  2026-09-28

  Build a transient Cas12a editing workflow around mRNA delivery, crRNA design, and orthogonal readouts—not a one-size-fits-all dose. This guide translates Cpf1 engineering evidence into practical controls, optimization steps, and troubleshooting while distinguishing the cited study’s pseudouridine findings from the product’s m1Ψ modification.

• LL-37 Mimetics Show Selective Antibiofilm Activity

  2026-09-27

  Luo et al. compared LL-37 with the truncated peptides KE-18 and KR-12 against three clinically relevant microorganisms, finding that antimicrobial potency did not predict antibiofilm effects. KE-18 stood out for preventing biofilm formation, including at sub-MIC concentrations, while neither truncated peptide inhibited established biofilms in the reported assays.

• a-MSH, Amide: Translating Pigmentation Signals

  2026-09-26

  a-MSH, amide is a defined melanocortin peptide for probing how receptor stimulation shapes melanin production. This article connects its MC1R-centered role in pigmentation regulation research with findings from a study of glabridin, resveratrol, and ellagic acid, then turns those insights into practical guidance for experimental design. It also distinguishes a pigmentation-induction tool from antimelanogenic interventions and explains what the available evidence can—and cannot—support when researchers bridge pigmentation studies to inflammation.

• Staurosporine in Assay-Ready Cell Research

  2026-09-25

  Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor used to probe apoptosis and kinase signaling. This article examines how cell banking and post-thaw recovery can shape apoptosis-assay interpretation, drawing on new THP-1 cryopreservation research.

• Phosphatase Inhibitor Cocktail for Bone Signaling

  2026-09-25

  Preserve labile phosphorylation signals during studies of prenatal dexamethasone exposure, MKP-1, and osteoprogenitor biology with a dual-component inhibitor system. Its sequential 100X format supports practical lysate workflows while keeping phosphoprotein readouts distinct from the histone-methylation mechanisms explored in the reference study.

7776 records 1/519 page Next 12345 下5页 Last page